Vident Investment Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,594
Closed -$1.59M 131
2023
Q2
$1.59M Sell
5,594
-7,997
-59% -$2.28M 0.05% 369
2023
Q1
$3.78M Buy
13,591
+4,751
+54% +$1.32M 0.12% 186
2022
Q4
$2.45M Buy
8,840
+2,469
+39% +$684K 0.09% 247
2022
Q3
$1.62M Buy
6,371
+1,077
+20% +$275K 0.05% 432
2022
Q2
$1.07M Sell
5,294
-39,291
-88% -$7.95M 0.03% 598
2022
Q1
$9.39M Buy
44,585
+8,854
+25% +$1.86M 0.24% 91
2021
Q4
$8.57M Buy
35,731
+9,168
+35% +$2.2M 0.22% 90
2021
Q3
$7.52M Sell
26,563
-3,583
-12% -$1.01M 0.23% 81
2021
Q2
$10.4M Sell
30,146
-1,896
-6% -$657K 0.32% 63
2021
Q1
$8.96M Buy
32,042
+7,992
+33% +$2.24M 0.3% 60
2020
Q4
$5.89M Buy
24,050
+3,148
+15% +$771K 0.24% 74
2020
Q3
$5.93M Buy
20,902
+2,579
+14% +$732K 0.29% 72
2020
Q2
$4.9M Sell
18,323
-2,252
-11% -$603K 0.26% 77
2020
Q1
$6.51M Buy
20,575
+2,532
+14% +$801K 0.43% 60
2019
Q4
$5.35M Buy
18,043
+11,787
+188% +$3.5M 0.33% 46
2019
Q3
$1.46M Buy
6,256
+1,554
+33% +$362K 0.13% 117
2019
Q2
$1.1M Buy
4,702
+3,444
+274% +$806K 0.09% 160
2019
Q1
$297K Sell
1,258
-1,306
-51% -$308K 0.02% 670
2018
Q4
$772K Buy
2,564
+266
+12% +$80.1K 0.04% 477
2018
Q3
$812K Buy
2,298
+581
+34% +$205K 0.03% 532
2018
Q2
$499K Buy
1,717
+739
+76% +$215K 0.02% 661
2018
Q1
$259K Sell
978
-1,111
-53% -$294K 0.01% 807
2017
Q4
$665K Buy
2,089
+1,104
+112% +$351K 0.03% 472
2017
Q3
$308K Buy
+985
New +$308K 0.02% 621
2017
Q1
Sell
-1,172
Closed -$332K 428
2016
Q4
$332K Buy
+1,172
New +$332K 0.04% 365
2016
Q1
Sell
-4,708
Closed -$1.44M 373
2015
Q4
$1.44M Sell
4,708
-8,451
-64% -$2.59M 0.18% 254
2015
Q3
$3.84M Buy
13,159
+3,711
+39% +$1.08M 0.53% 10
2015
Q2
$3.82M Sell
9,448
-763
-7% -$308K 0.51% 25
2015
Q1
$4.31M Buy
+10,211
New +$4.31M 0.87% 2